Clinical Trial Update: Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating corneal crosslinking in keratoconus and post-refractive ectasia completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus
• Post-refractive Ectasia

Drugs mentioned

• Corneal crosslinking

Snippet

Sponsor: Price Vision Group | Conditions: Keratoconus, Post-Refractive Ectasia | Phase 2 | Status: COMPLETED | Results posted: 2018-05-04